Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-24 @ 7:08 PM
NCT ID:
NCT00523757
Eligibility Criteria:
Inclusion Criteria:
1. HF by Framingham criteria
2. At least one admission to hospital for HF within the last 180 days
3. New York Heart Association Class II thru IV
4. Echocardiographic criteria:At least moderate diastolic dysfunction, Ejection fraction \>45%
Exclusion Criteria:
1. Creatinine clearance \<40 mls/min/1.73m2
2. Potassium \>5.0 mmol/L
3. Recent acute coronary syndrome in the prior 4 weeks
4. Planned revascularization, defibrillator or pacemaker in next 4 months
5. Known previous intolerance to aldosterone antagonist
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT00523757
Study Brief:
Protocol Section:
NCT00523757